| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arrhythmias, Cardiac | D001145 | 42 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Reperfusion Injury | D015427 | 65 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Hypotension | D007022 | 41 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
N-(1R-methyl-2-hydroxy-ethyl) arachidonoyl amine
N-(1r-methyl-2-hydroxy-ethyl) arachidonoyl amine is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 991 references associated with N-(1R-methyl-2-hydroxy-ethyl) arachidonoyl amine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for N-(1R-methyl-2-hydroxy-ethyl) arachidonoyl amine
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with N-(1R-methyl-2-hydroxy-ethyl) arachidonoyl amine
NCBI Entrez Crosslinks
All references with N-(1R-methyl-2-hydroxy-ethyl) arachidonoyl amine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Grzeda E et al. | Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus. | 2015 | J. Physiol. Pharmacol. | pmid:26084216 |
| Orellana-Serradell O et al. | Proapoptotic effect of endocannabinoids in prostate cancer cells. | 2015 | Oncol. Rep. | pmid:25606819 |
| den Boon FS et al. | Endocannabinoids produced upon action potential firing evoke a Cl(-) current via type-2 cannabinoid receptors in the medial prefrontal cortex. | 2014 | Pflugers Arch. | pmid:24671573 |
| Järbe TU et al. | Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats. | 2014 | Psychopharmacology (Berl.) | pmid:24005529 |
| Levchuk NI | [Influence of metanandamide on steroidogenesis in rat adrenocorticocytes in vitro]. | 2013 Jul-Aug | Ukr Biokhim Zh (1999) | pmid:24319977 |
| Korossy-Mruk E et al. | Neonatal DSP-4 treatment modifies antinociceptive effects of the CB1 receptor agonist methanandamide in adult rats. | 2013 | Neurotox Res | pmid:22488162 |
| Ribeiro R et al. | Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists. | 2013 | Prostaglandins Other Lipid Mediat. | pmid:23219970 |
| Patel SK et al. | A role for two-pore potassium (K2P) channels in endometrial epithelial function. | 2013 | J. Cell. Mol. Med. | pmid:23305490 |
| Innamaa A et al. | Expression and prognostic significance of the oncogenic K2P potassium channel KCNK9 (TASK-3) in ovarian carcinoma. | 2013 | Anticancer Res. | pmid:23564779 |
| Xapelli S et al. | Activation of type 1 cannabinoid receptor (CB1R) promotes neurogenesis in murine subventricular zone cell cultures. | 2013 | PLoS ONE | pmid:23704915 |